In addition to pursuing our own activity, our ambition is to become a benchmark player in initiation and development of medical and paramedical companies. Our investments can relate to the development of drug candidates (BioTech) as well as medical devices (MedTech).
Neovacs has launched a seed fund dedicated to financing innovative companies in the seed stage of developing treatments for COVID 19 and more generally, the fight against pandemics. The chosen theme is: "Current and future pandemics: therapeutic strategies (vaccines, antivirals) against SARS COVID 2 and other natural microorganisms posing a global catastrophic biological risk."
Do not hesitate to contact us if you are looking for funding (seed / round A).